Silent Nucleotide Substitution in the Sterol 27-Hydroxylase Gene (CYP 27) Leads to Alternative Pre-mRNA Splicing by Activating a Cryptic 5‘ Splice Site at the Mutant Codon in Cerebrotendinous Xanthomatosis Patients
- 1 March 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 37 (13) , 4420-4428
- https://doi.org/10.1021/bi972940a
Abstract
A functionally silent nucleotide substitution of the sterol 27-hydroxylase gene (CYP 27), identified in two families with cerebrotendinous xanthomatosis (CTX), was confirmed to cause alternative pre-mRNA splicing of the gene. Full-length RT-PCR analysis of the CYP 27 gene in a patient from one of the CTX families revealed one major and an additional faint band. Sequence analysis of the cloned RT-PCR product showed three species of cDNA: 3' terminal 13 bp of exon 2 deleted cDNA, exon 2 skipped cDNA, and full-length cDNA with a functionally silent G to T mutation at codon 112 (GGG 112Gly to GGT 112Gly). Only a single base change was identified by genomic DNA sequence analysis of the CYP 27 gene in the patient: T replaced G at the third position of codon 112, 13 bp upstream from the 3' terminus of exon 2. Transfection of constructed minigenes, with or without the mutation, confirmed that this silent mutation resulted in alternative pre-mRNA splicing by activating a cryptic 5' splice site around the mutant codon. The mutation was also identified in two patients from another CTX family, with a compound heterozygous pattern of A for G substitution at codon 372, a mutation reported previously by our group. The results elucidate a novel molecular basis for the CTX and suggest the significance of a silent nucleotide substitution with regard to pre-RNA splicing.Keywords
This publication has 10 references indexed in Scilit:
- Cerebrotendinous xanthomatosis: a family study of sterol 27-hydroxylase mutations and pharmacotherapyQJM: An International Journal of Medicine, 1996
- Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.Journal of Clinical Investigation, 1993
- Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosisMetabolism, 1993
- Atherogenic risk factors in cerebrotendinous xanthomatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- Quantitative estimation of minor mRNAs by cDNA‐polymerase chain reactionEuropean Journal of Biochemistry, 1990
- Quantitative analysis of sterols in serum by high-performance liquid chromatography : Application to the biochemical diagnosis of cerebrotendinous xanthomatosisJournal of Chromatography A, 1987
- Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitroCell, 1987
- Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis.Journal of Clinical Investigation, 1986
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- Cerebrotendinous XanthomatosisArchives of Neurology, 1968